AP Pharma Inc. (APPA) Swings To Q4 Profit
AP Pharma Inc. (NASDAQ: APPA) reported Q4 EPS of $0.04, versus ($0.05) last year.
You May Also Be Interested In
- UPDATE: Methode Electronics (MEI) Tops Q2 EPS by 16c; Boosts FY14 Outlook
- Conn's, Inc. (CONN) Tops Q3 EPS by 2c; Boosts FY14 EPS Outlook, Guides FY15 EPS
- Exa (EXA) Tops Q3 EPS by 1c; Guides Q4, FY14 Revs
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!